EU-supported research finds proteomic signature in plasma
Research into biomarkers for Alzheimer’s disease has shown that plasma is a potentially rich source of these indicators, according to an investigator from King’s College London.
News
Vaccine developer to set up fund for seed capital
The world’s largest developer of candidate vaccines for acquired immune deficiency syndrome (AIDS) plans to set up a new fund to locate and develop new ideas relating to vaccines. Details were to be announced by the end of June.